Clinical Trial Update: Influence of Age, Sepsis and SLCO1A2 Polymorphisms on Rocuronium Pharmacokinetics [Phase 4]

View source ↗

Summary

A Phase 4 trial update investigating how age, sepsis, and SLCO1A2 genetics affect rocuronium pharmacokinetics in septic conditions; the study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Rocuronium (rocuronium bromide)

Snippet

Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho | Conditions: Sepsis, Systemic Inflammatory Response Syndrome | Phase 4 | Status: COMPLETED